XTL Biopharmaceuticals Ltd
Pharmaceutical company · New York, United States · Nasdaq: XTLB
XTL Biopharmaceuticals Ltd is a pharmaceutical company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker XTLB. It has reported private securities offerings to the US SEC, most recently $2.8 million sold in a notice filed in 2017.
XTL Biopharmaceuticals at a glance
What does XTL Biopharmaceuticals do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $2.8 million sold (2017).
Frequently asked questions about XTL Biopharmaceuticals
Where is XTL Biopharmaceuticals headquartered?
XTL Biopharmaceuticals Ltd is headquartered in New York, United States.
What does XTL Biopharmaceuticals do?
XTL Biopharmaceuticals Ltd is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is XTL Biopharmaceuticals a public company?
Yes. XTL Biopharmaceuticals Ltd trades on Nasdaq under the ticker XTLB.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences